rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
8
|
pubmed:dateCreated |
2000-5-10
|
pubmed:abstractText |
Evidence that avoiding axillary lymph node dissection (AxD) strikes an appropriate balance between morbidity and recurrence risk in patients with invasive breast carcinoma generally is anecdotal and without a formally quantified basis. The current study presents a decision analysis of the difference in 5-year disease free survival (DFS) rate between treatment scenarios with and without routine AxD.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0008-543X
|
pubmed:author |
|
pubmed:copyrightInfo |
Copyright 2000 American Cancer Society.
|
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
88
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1852-62
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:10760762-Adult,
pubmed-meshheading:10760762-Aged,
pubmed-meshheading:10760762-Antineoplastic Agents,
pubmed-meshheading:10760762-Antineoplastic Agents, Hormonal,
pubmed-meshheading:10760762-Axilla,
pubmed-meshheading:10760762-Breast Neoplasms,
pubmed-meshheading:10760762-Decision Support Techniques,
pubmed-meshheading:10760762-Disease-Free Survival,
pubmed-meshheading:10760762-Female,
pubmed-meshheading:10760762-Humans,
pubmed-meshheading:10760762-Lymph Node Excision,
pubmed-meshheading:10760762-Lymph Nodes,
pubmed-meshheading:10760762-Lymphatic Metastasis,
pubmed-meshheading:10760762-Middle Aged,
pubmed-meshheading:10760762-Prognosis,
pubmed-meshheading:10760762-Risk Assessment,
pubmed-meshheading:10760762-Tamoxifen
|
pubmed:year |
2000
|
pubmed:articleTitle |
A decision analysis of the effect of avoiding axillary lymph node dissection in low risk women with invasive breast carcinoma.
|
pubmed:affiliation |
Breast Cancer Outcomes Unit, British Columbia Cancer Agency, Vancouver, British Columbia, Canada.
|
pubmed:publicationType |
Journal Article
|